Antibody-mediated rejection (AMR) is one of the most common causes of kidney transplant failure. To date, however, no treatment has proven effective in combating this complication in the long term. As part of an international and multidisciplinary clinical study led by Georg Böhmig and Katharina Mayer, Clinical Division of Nephrology and Dialysis, Department of Medicine […]
Read More… from Kidney transplantation: New therapy proven effective
Using “superhero bugs” and AI to save lives from infections: Curtin University research is aiming to combine artificial intelligence with natural, infection-fighting viruses to help save lives from an increasingly common medical emergency found in hospitals. Common bacterial infections such as golden staph (staphylococcus) and pseudomonas can quickly put a person’s life at risk and […]
Read More… from Using “superhero bugs” and AI to save lives from infections
Major new research study to improve antibiotic prescribing for urinary tract infections (UTIs) in primary care New research led by the University of Bristol aims to help GPs choose the best antibiotic for treating UTIs and reducing antimicrobial resistance (AMR), thanks to a £3 million award by the National Institute for Health and Care Research […]
Global Antibiotic Research and Development Partnership: The University of Liverpool and the Global Antibiotic Research and Development Partnership (GARDP) have signed a Memorandum of Understanding to collaborate on new projects to address antimicrobial resistance (AMR) for the benefit of public health. Since 2018, GARDP and the University of Liverpool have been working together to advance new […]
Read More… from Global Antibiotic Research and Development Partnership
Researcher awarded €1.5 million to create new antibiotics that can kill drug resistant superbugs. A Queen’s University Belfast researcher has been awarded €1.5 million for a mission to help develop new types of antibiotics that can target and kill bacteria that are resistant to current antibiotics. Antimicrobial resistance is a major global health threat, accounting […]
Read More… from Grant to create new antibiotics for superbugs
Exeter awarded £14 million for antimicrobial resistance research to fight “next global pandemic” The University of Exeter and collaborators have recently been awarded £14 million for antimicrobial resistance (AMR) research – widely acknowledged as the “next global pandemic” AMR occurs when bacteria, viruses, fungi and parasites evolve to become resistant to commonly used antimicrobial drugs […]
Read More… from Exeter awarded £14 million to fight “next global pandemic”
Lack of innovation set to undermine antibiotic performance and health gains: Development of new antibacterial treatments is inadequate to address the mounting threat of antibiotic resistance, according to the annual pipeline report by the World Health Organization. The 2021 report describes the antibacterial clinical and preclinical pipeline as stagnant and far from meeting global needs. […]
The spectacular structure of the protective armour of superbug C.difficile has been revealed for the first time showing the close-knit yet flexible outer layer – like chain mail. This assembly prevents molecules getting in and provides a new target for future treatments, according to the scientists who have uncovered it. Publishing in Nature Communications, the […]
Read More… from The protective armour of superbug C.difficile revealed
Surveillance of antimicrobial resistant diseases could be more challenging outside of the European Union: In a new report from the Microbiology Society, experts from around the UK explain the desperate need for long-term and ambitious funding for surveillance and research into antimicrobial resistance (AMR). The next pandemic is likely to be associated with antimicrobial resistance, […]
Read More… from Antimicrobial resistant diseases outside of EU